190 related articles for article (PubMed ID: 19366441)
1. Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study.
Sicras-Mainar A; Rejas J; Navarro R; Blanca M; Morcillo A; Larios R; Velasco S; Villarroya C
Arthritis Res Ther; 2009; 11(2):R54. PubMed ID: 19366441
[TBL] [Abstract][Full Text] [Related]
2. Effect of fibromyalgia syndrome on the health-related quality of life and economic burden in Korea.
Kim SK; Kim SH; Lee CK; Lee HS; Lee SH; Park YB; Park HJ; Son MJ; Lee SS
Rheumatology (Oxford); 2013 Feb; 52(2):311-20. PubMed ID: 23024016
[TBL] [Abstract][Full Text] [Related]
3. [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].
Marschall U; Arnold B; Häuser W
Schmerz; 2011 Aug; 25(4):402-4, 406-10. PubMed ID: 21818719
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
5. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
7. [Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings].
Sicras-Mainar A; Blanca-Tamayo M; Navarro-Artieda R; Rejas-Gutiérrez J
Aten Primaria; 2009 Feb; 41(2):77-84. PubMed ID: 19231702
[TBL] [Abstract][Full Text] [Related]
8. Health economic consequences related to the diagnosis of fibromyalgia syndrome.
Annemans L; Wessely S; Spaepen E; Caekelbergh K; Caubère JP; Le Lay K; Taïeb C
Arthritis Rheum; 2008 Mar; 58(3):895-902. PubMed ID: 18311794
[TBL] [Abstract][Full Text] [Related]
9. Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage.
Lind BK; Lafferty WE; Tyree PT; Diehr PK; Grembowski DE
Arthritis Rheum; 2007 Feb; 57(1):71-6. PubMed ID: 17266066
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic characteristics of patients with fibromyalgia syndrome.
Lachaine J; Beauchemin C; Landry PA
Clin J Pain; 2010 May; 26(4):284-90. PubMed ID: 20393262
[TBL] [Abstract][Full Text] [Related]
11. Fibromyalgia-related costs and loss of productivity: a substantial societal burden.
Lacasse A; Bourgault P; Choinière M
BMC Musculoskelet Disord; 2016 Apr; 17():168. PubMed ID: 27084363
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and healthcare utilisation patterns of high-cost beneficiaries in the Netherlands: a cross-sectional claims database study.
Wammes JJG; Tanke M; Jonkers W; Westert GP; Van der Wees P; Jeurissen PP
BMJ Open; 2017 Nov; 7(11):e017775. PubMed ID: 29133323
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and healthcare costs of patients with fibromyalgia syndrome.
Berger A; Dukes E; Martin S; Edelsberg J; Oster G
Int J Clin Pract; 2007 Sep; 61(9):1498-508. PubMed ID: 17655684
[TBL] [Abstract][Full Text] [Related]
15. Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia.
White LA; Robinson RL; Yu AP; Kaltenboeck A; Samuels S; Mallett D; Birnbaum HG
J Pain; 2009 Sep; 10(9):976-83. PubMed ID: 19556168
[TBL] [Abstract][Full Text] [Related]
16. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
[TBL] [Abstract][Full Text] [Related]
17. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
18. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
19. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
20. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.
White RR; Lenhart G; Singhal PK; Insinga RP; Itzler RF; Pellissier JM; Segraves AW
Pharmacoeconomics; 2009; 27(9):781-92. PubMed ID: 19757871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
